Newsroom

Sorted by: Latest

-

Old Spice Teams Up With Iconic R&B Group to Ignite Beloved "Mom Song" in New Campaign: 'The End of Adolescents'

CINCINNATI--(BUSINESS WIRE)--Old Spice, the iconic brand dedicated to the journey from boyhood to manhood, has launched its revitalized "Mom Song" campaign, 'The End of Adolescents.’ Old Spice licensed the song ‘End of the Road’ by the legendary R&B group, Boyz II Men. The campaign brings back the universally relatable experience of moms grappling with their sons' newfound manliness, a theme that was first introduced by Old Spice over a decade ago in the original, “Mom Song.” The new 60-sec...
-

Tech Startup Hosel Takes Swing at Global Second-Hand Golf Equipment Market

EDINBURGH, Scotland--(BUSINESS WIRE)--Golf tech startup Hosel is aiming to take a swing at a global second-hand club, equipment, and accessory market valued at $3 billion. With a growing trend for golfers seeking “nearly new” golf clubs, Hosel’s platform helps golfers compare, buy and trade pre-owned clubs from trusted sellers in a market dominated by non-specialist behemoth players like eBay and characterised by issues around pricing, quality of product, and counterfeit goods. As resale become...
-

Butterfly Network Appoints David Horsley as Senior Vice President, Innovation – Butterfly Embedded™

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of David Horsley, Ph.D. as Senior Vice President of Innovation – Butterfly Embedded™ to scale its Ultrasound-on-Chip™ co-development and licensing initiative. In this role, Dr. Horsley will lead strategy and go-to-market for Butterfly Embedded, overseeing new product...
-

Guardant Health’s Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the Shield™ by Guardant blood-based screening test is now widely accessible for physician order through the nationwide connectivity of Quest Diagnostics, equipping clinicians with access to blood-based screening innovation for colorectal cancer (CRC) through one of the largest diagnostic ecosystems in the United States. Shield is the first and only blood test to rec...
-

Sectigo Appoints Clint Maddox as President, Global Field Operations

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Sectigo, a global leader in automated Certificate Lifecycle Management (CLM) and digital certificates, today announced the appointment of Clint Maddox as President, Global Field Operations. In this role, Maddox will lead Sectigo’s global revenue and go-to-market organization—spanning sales, marketing, and channel operations—further accelerating the company’s growth and expanding its worldwide footprint. Maddox joins at a pivotal moment. Following a record-bre...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest S&P 500 Dividend Aristocrats Target Income UCITS ETF 09.03.2026 KNG.LN IE000SNMGYT5 550,002.00 USD 11,523,331.52 20.951  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - November 09.03.2026 GNOV LN IE000OJ31JQ4 1,000,002.00 USD 35,004,439.26 35.004  ...
-

Nexpring Health investit dans May Health pour faire progresser une technologie novatrice dans le traitement de l’infertilité liée au SOPK

BEVERLY, Massachusetts--(BUSINESS WIRE)--Nexpring Health, leader mondial des solutions de procréation médicalement assistée (PMA), a annoncé aujourd’hui un investissement stratégique dans May Health, une société de dispositifs médicaux pionnière dans une nouvelle approche thérapeutique pour les femmes souffrant d’infertilité liée au syndrome des ovaires polykystiques (SOPK). Nexpring Health s’est associé à May Health pour un tour de table de 10 millions d’euros (11,7 millions de dollars) aux cô...
-

Nexpring Health invierte en May Health para desarrollar una nueva tecnología para tratar la infertilidad relacionada con el síndrome de ovario poliquístico (SOP)

BEVERLY, Massachusetts--(BUSINESS WIRE)--Nexpring Health, líder internacional en soluciones de tecnología de reproducción asistida (TRA), ha anunciado hoy una inversión estratégica en May Health, una empresa de dispositivos médicos pionera en un novedoso enfoque terapéutico para mujeres con infertilidad relacionada con el síndrome de ovario poliquístico (SOP). Nexpring Health se ha sumado a la ronda de financiación de 10 millones de euros (11,7 millones de dólares) de May Health junto con inver...
-

A Wolters Kluwer közzétette a 2026-os A jövő jogásza felmérését, amely rávilágít a mesterséges intellingencia gyors térnyerésére és a szakmán belüli erőviszonyok átrendeződésére

NEW YORK--(BUSINESS WIRE)--A Wolters Kluwer Legal & Regulatory üzletága nyilvánosságra hozta a 2026-os nemzetközi, A jövő jogásza felmérés eredményeit, amely kilenc európai országban, az Egyesült Államokban és Kínában dolgozó ügyvédek és vállalati jogi szakemberek legfontosabb visszajelzéseit gyűjti össze. A kutatás egy olyan jogi ágazat képét rajzolja ki, amely igyekszik megbirkózni a mesterséges intelligencia gyors ütemű terjedésével: ez az ambiciózus átállás jelentős és régóta várt haték...